Select Page

US FDA Guidances Published in September 2022

by | Oct 3, 2022 | Guidances, Regulatory

The US FDA has issued a series of guidance’s to assists the sponsor and applicant in the generic drug development. The September month has around 06 new/revised guidance under GDUFA and ICH provisions. The links of the guidance’s are provided below for quick review...
Don`t copy text!